Distinguished Faculty:
Cherif Benattia, M.D., former Vice President, Pharmacovigilance & Public Health, Vertex Pharmaceuticals, Inc.; CEO, Patient Safety 1st, APhaRC
Gary Bloomgren, M.D., MBA, Executive Director, Global Safety, Amylin Pharmaceuticals
- Carmen Bozic, M.D., Vice President and Global Head, Drug Safety and Risk Management, Biogen Idec Inc.
- Ralph B. D'Agostino Sr., Ph.D., Professor of Mathematics, Statistics, and Public Health, Boston University
- Kelly D. Davis, M.D., Vice President, Epidemiology & Risk Management, United BioSource Corporation
- Sybil Eng, M.D., Senior Director, Specialty Care BU Group Head, Epidemiology, Safety and Risk Management, Pfizer, Inc.
- John Ferguson, M.D., Ph.D., Vice President & Global Head, Pharmacovigilance & Medical Safety, Novartis Vaccines & Diagnostics
- Michael Forstner, Ph.D., Drug Safety Risk Management, F. Hoffman-La Roche; former Senior Risk Engineer, Zurich Financial Services
- Elizabeth Garrard, Pharm.D., R.Ph., Chief Safety Officer, Drug Safety Alliance, Inc.
- Nicolle Gatto, Ph.D., Senior Director, Oncology BU Group Head, Epidemiology, Safety and Risk Management, Pfizer, Inc.
- Jamie Geier, Ph.D., Associate Director, Epidemiology, Safety and Risk Management, Pfizer, Inc.
- Eric Gemmen, MA, Senior Director, Medical Affairs, Epidemiology & Outcomes Research, Quintiles Late Phase
- Sonia Hernández-Díaz, M.D., DrPH, Associate Professor, Epidemiology, Director, Pharmacoepidemiology Program, Harvard School of Public Health
- Michael Hill, Project Manager, Registry and Observational Studies, Covance Periapproval Services
- Sean D. Kennedy, MPH, Director, Registry and Observational Studies, Covance Periapproval Services
- Aliceson Y. King, M.D.,MPH, Medical Director, Drug Safety Alliance
- Uwe Maennl, M.D., Ph.D., MBA, Vice President, Global Head Pharmacovigilance, Quintiles
- Lukas Makris, Ph.D., Senior VP & Chief Statistician, United BioSource Corporation
- Heather Morel, Vice President and General Manager, Reimbursement & Access Services, McKesson Specialty Care Solutions
- Yola Moride, Ph.D., Associate Professor of Pharmacy, Université de Montréal; President, International Society for Pharmacoepidemiology (ISPE)
- John Parkinson, Ph.D., Director, GPRD, Medicines & Healthcare Products Regulatory Agency (MHRA)
- Kelly Posner, Ph.D., Principal Investigator, Columbia/FDA Classification Project for Drug Safety Analyses, Director of the Center for Suicide Risk Assessment, Columbia University, Child Psychiatry, New York State Psychiatric Institute/Columbia University
- Kamala Rai, M.D., Head-Clinical Development, International Clinical Research Operations, Novartis India Limited
- Jack A. Reynolds, former-Senior Vice President of Research and Development and Worldwide Head of Safety Sciences and Comparative Medicine, Pfizer; Chairman, Drug Safety Executive Council (DSEC)
- Jill Robinson, R.Ph., M.B.A., Vice President, Global Safety Surveillance & Epidemiology, Wyeth
- Peggy Schrammel, Vice President, Registries and Post Approval Development, United BioSource Corporation
- Bob Sharrar, M.D., MSc, BA, Executive Director, Epidemiology and Risk Management, United BioSource Corporation
- Cathy Sigler, Ph.D., M.P.H., Senior Director, Epidemiology Risk Management, United BioSource Corporation
- Gary Slatko, M.D., MBA, Chief Medical Officer, ParagonRx
- Abbe Steel, Executive Director, Trial Enhancement Services, United BioSource Corporation
- Catherine Stokes, President & CEO, Drug Safety Alliance, Inc. (DSA)
- Jan-Willem van der Velden, M.D., Sr. VP Global Drug Safety, International Institute for the Safety of Medicines Ltd.
For questions or suggestions about the meeting, please contact:
Micah Lieberman
Executive Director, Conferences
Pharmaceutical Strategy Series
Cambridge Healthtech Institute (CHI)
T: (+1) 541.482.4709
E: mlieberman@pharmaseries.com
For exhibit, partnering and sponsorship information, please contact:
Arnold Wolfson
Business Development Manager
Pharmaceutical Strategy Series
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5431
E: awolfson@healthtech.com
For media and association partnerships, please contact:
Alec Frazier
Manager, Marketing
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5459
E: afrazier@healthtech.com